alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
AMENDMENT
TO OPTION #23


(Christopher
David, Grant Date February 19, 2016)


 


Dated
as of April 20, 2018


 


THIS
AMENDMENT TO OPTION (the “Amendment”), dated as of the date first set forth above (the “Effective Date”)
is entered into by and between Novo Integrated Sciences Inc., a Nevada corporation (the “Company”) and Christopher
David (the “Holder” or “Optionee”). Each of the Company and Holder may be referred to herein individually
as a “Party” and collectively as the “Parties.”


 


WHEREAS,
on February 19, 2016 the Company issued to Holder an option to purchase 500,000 shares of common stock of the Company at an exercise
price of USD$0.16 (the “Option”, “Option #23”) which Option vested on the Grant Date and is currently
set to expire on February 19, 2021 (the “Expiration Date”);


 


WHEREAS,
the Parties now desire to amend the Option #23 Expiration Date, as set forth below; and


 


NOW,
THEREFORE, in consideration of the foregoing, and for other good and valuable consideration, the receipt and adequacy of which
are hereby acknowledged, the Parties agree as follows:


 


	1.	Amendment.
    The word and number “five (5)” in both Section 1(b) of the Option Agreement and in paragraph 2 of the Certificate
    of Option for Option #23 are hereby amended to read “eight (8)”. This Amendment changes the Expiration Date of
    Option #23 to February 19, 2024.
	 	 
	2.	Miscellaneous.
    This Amendment shall be deemed part of but shall take precedence over and supersede any provisions to the contrary contained
    in the Option. Except as specifically modified hereby, all of the provisions of the Option shall remain in full force and
    effect. This Amendment may be executed in counterparts, each of which shall be deemed an original, but all of which together
    shall be deemed to be one and the same agreement. A signed copy of this Amendment delivered by facsimile, e-mail or other
    means of electronic transmission shall be deemed to have the same legal effect as delivery of an original signed copy of this
    Amendment.


 


[Signatures
appear on following page]


 




    	 	1	 



     


    

 


IN
WITNESS WHEREOF, the Parties have executed this Amendment as of the Effective Date.


 


	 	Novo Integrated Sciences, Inc.
	 	 	 
	(SEAL)	By:	/s/
    Pierre Dalcourt
	 	Name:
    	Pierre
    Dalcourt
	 	Title:
    	Board
    Chairman
	 	 	 
	 	By:
    	/s/
    Michael Gaynor
	 	Name:
    	Michael
    Gaynor
	 	Title:
    	Secretary
    and Director
	 	 	 
	 	Option #21 Optionee 
	 	 	 
	 	By:
    	/s/
    Christopher David
	 	Name:
    	Christopher
    David, Individual


 




    	 	2
UNPUBLISHED

UNITED STATES COURT OF APPEALS

FOR THE FOURTH CIRCUIT

No. 96-6863

UNITED STATES OF AMERICA,

Plaintiff - Appellee,

versus

LAMARK M. FOGLE, a/k/a Big Mark,

Defendant - Appellant.

Appeal from the United States District Court for the Eastern District of Virginia, at Richmond. James R. Spencer, District Judge.

(CR-96-79, CA-96-216)

Submitted: October 3, 1996 Decided: October 15, 1996

Before ERVIN, LUTTIG, and MICHAEL, Circuit Judges.

Dismissed by unpublished per curiam opinion.

Lamark M. Fogle, Appellant Pro Se. William Neil Hammerstrom, Jr.,

OFFICE OF THE UNITED STATES ATTORNEY, Alexandria, Virginia; John

Granville Douglass, OFFICE OF THE UNITED STATES ATTORNEY, Richmond,

Virginia, for Appellee.

Unpublished opinions are not binding precedent in this circuit.

See Local Rule 36(c).
2

PER CURIAM:

Appellant appeals from the district court's order denying his

28 U.S.C. § 2255 (1988), amended by Antiterrorism and Effective

Death Penalty Act of 1996, Pub. L. No. 104-132, 110 Stat. 1214,

motion. We have reviewed the record and the district court's opinion and find no reversible error. Accordingly, we deny a certificate of appealability and dismiss substantially on the reasoning of

the district court. United States v. Fogle, Nos. CR-96-79; CA-96-

216 (E.D. Va. May 10, 1996); see Hill v. Lockhart, 474 U.S. 52

(1985). We dispense with oral argument because the facts and legal

contentions are adequately presented in the materials before the

court and argument would not aid the decisional process.

DISMISSED
[Federal Register Volume 82, Number 187 (Thursday, September 28, 2017)]
[Notices]
[Page 45261]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-20808]


-----------------------------------------------------------------------

DEPARTMENT OF COMMERCE

Foreign-Trade Zones Board

[S-11-2017]


Approval of Subzone Status; LT Autos, LLC, Ponce, Puerto Rico

    On January 31, 2017, the Executive Secretary of the Foreign-Trade 
Zones (FTZ) Board docketed an application submitted by CODEZOL, C.D., 
grantee of FTZ 163, requesting subzone status subject to the existing 
activation limit of FTZ 163, on behalf of LT Autos, LLC, in Ponce, 
Puerto Rico. The application was amended on June 28, 2017.
    The amended application was processed in accordance with the FTZ 
Act and Regulations, including notices in the Federal Register inviting 
public comment (82 FR 9370-9371, February 6, 2017; 82 FR 32530-32531, 
July 14, 2017). The FTZ staff examiner reviewed the amended application 
and determined that it meets the criteria for approval. Pursuant to the 
authority delegated to the FTZ Board's Executive Secretary (15 CFR 
400.36(f)), the amended application to establish Subzone 163J was 
approved on September 7, 2017, subject to the FTZ Act and the Board's 
regulations, including Section 400.13, and further subject to FTZ 163's 
923.36-acre activation limit.

    Dated: September 22, 2017.
Andrew McGilvray,
Executive Secretary.
[FR Doc. 2017-20808 Filed 9-27-17; 8:45 am]
 BILLING CODE 3510-DS-P
#### Angela Mayers, Respondent, v Paul S. Colcher et al., Defendants, and Saroj Khaneja et al., Appellants.

[665 NYS2d *102877]

—Order, Supreme Court, Bronx County (Alan Saks, J.), entered November 19, 1996, which denied a motion by defendants-appellants, pathologists and laboratory, for summary judgment dismissing the complaint against movants, unanimously reversed, on the law, without costs, and the motion granted. The Clerk is directed to enter judgment in favor of defendants-appellants dismissing the complaint as against them.

Appellants met their burden as movants of establishing, prima facie, a lack of negligence in their handling and analysis of certain tissue samples. Respondent, in turn, failed to rebut that showing with competent evidence to support the conclusion of her expert that the samples were contaminated as the result of negligence by appellants (see, *Burt v Lenox Hill Hosp.,*141 AD2d 378). Concur—Sullivan, J. P., Williams, Mazzarelli, Andrias and Colabella, JJ.
#### The People of the State of New York, Respondent, v Thomas Perez, Appellant.

(Appeal No. 2.)

[858 NYS2d 646]

Appeal from a new sentence of the Monroe County Court (Stephen R. Sirkin, J.), rendered November 17, 2005 imposed upon defendant’s conviction of criminal possession of a controlled substance in the first degree. Defendant was resentenced pursuant to the 2004 Drug Law Reform Act upon his 2005 conviction.

It is hereby ordered that the sentence so appealed from is unanimously affirmed. Present—Scudder, P.J., Lunn, Fahey, Pine and Gorski, JJ.
Exhibit 32.0

Certification of the Chief Executive Officer and Chief Accounting Officer

Pursuant to 18 U.S.C. Section 1350,

as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

with Respect to the Annual Report on Form 10-K

for the Year Ended December 31, 2009

Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, Chapter 63 of Title
18, United States Code), each of the undersigned officers of Vermillion, Inc., a Delaware corporation (the Company), does hereby certify, to the best of such officers knowledge, that:



|1. | The Companys annual report on Form 10-K for the year ended December 31, 2009, (the Form 10-K) fully complies with the
requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended (the Exchange Act); and
|-- | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



|2. | Information contained in the Form 10-K fairly presents, in all material respects, the financial condition and results of operations of the Company.
|-- | ---------------------------------------------------------------------------------------------------------------------------------------------------



|                   |  |  |  |                                                             
|------------------ |  |  |  | ------------------------------------------------------------
|Date: May 20, 2010 |  |  |  | /s/ Gail S. Page                                            
|                   |  |  |  | Gail S. Page                                                
|                   |  |  |  | Executive Chairperson, President and Chief Executive Officer
|                   |  |  |  | (Principal Executive Officer)                               
|                   |  | 
|Date: May 20, 2010 |  |  |  | /s/ John H. Tran                                            
|                   |  |  |  | John H. Tran                                                
|                   |  |  |  | Vice President of Finance and Chief Accounting Officer      
|                   |  |  |  | (Principal Financial and Accounting Officer)                

The certification set forth above is being furnished as an Exhibit solely pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
and is not being filed as part of the Form 10-K or as a separate disclosure document of the Company or the certifying officers.
EXHIBIT 22.1

               REPORT OF INDEPENDENT CERTIFIED PUBLIC ACCOUNTANTS



To the Board of Directors and Shareholders
of The Savannah Bancorp, Inc.:

     We have audited the consolidated balance sheet (not included herein) of The
Savannah  Bancorp,  Inc. and its  Subsidiaries  as of December 31, 1998, and the
accompanying  consolidated statements of income, changes in shareholders' equity
and cash  flows for the year then  ended.  These  financial  statements  are the
responsibility of the Company's management.  Our responsibility is to express an
opinion on these financial statements based on our audit.

     We conducted our audit in accordance with auditing  standards  accepted in
the United States. Those standards require that we plan and perform the audit to
obtain reasonable  assurance about whether the financial  statements are free of
material  misstatement.  An audit includes examining,  on a test basis, evidence
supporting  the amounts and  disclosures in the financial  statements.  An audit
also includes assessing the accounting principles used and significant estimates
made by  management,  as well as  evaluating  the  overall  financial  statement
presentation.  We  believe  that our audit  and the  reports of other  auditors
provide a reasonable basis for our opinion.

     In our opinion,  based on our audit, the financial  statements referred to
above present fairly, in all material  respects,  the financial  position of The
Savannah Bancorp, Inc. and Subsidiaries as of December 31, 1998, and the results
of  their  operations  and  cash  flows  of  The  Savannah  Bancorp,   Inc.  and
Subsidiaries  for the year ended December 31, 1998 in conformity with accounting
principles generally accepted in the United States.

/s/ ARTHUR ANDERSEN LLP

Jacksonville, Florida
January 25, 1999
**Exhibit 10.7A**

**AMENDMENT ONE**

**ALABAMA NATIONAL BANCORPORATION**

**PLAN FOR THE DEFERRAL OF COMPENSATION**

**BY KEY EMPLOYEES**

This Amendment One to the Alabama National BanCorporation Plan for the Deferral of Compensation by KeyEmployees is hereby made as of this 21st day of December, 2005, by Alabama National BanCorporation. 

**WITNESSETH:**

**WHEREAS**,Alabama National BanCorporation (“the Employer”) hereto established a nonqualified deferred compensation plan, namely, the Alabama National BanCorporation Plan for the Deferral of Compensation by Key Employees (the “Plan”);

**WHEREAS**, Q&A-21 of Notice 2005-1 and the Proposed Regulations under Section 409A of the Internal Revenue Code(collectively, “Section 409A”) provide that under a deferred compensation plan, initial elections for deferrals subject to Section 409A that relate all or in part to services performed on or before December 31, 2005, may be madeon or before March 15, 2005; ****

**WHEREAS**, the Employer permitted certain individuals to make initial elections under thePlan on or before March 15, 2005, for deferrals subject to Section 409A that relate all or in part to services performed on or before December 31, 2005; ****

**WHEREAS**, the Employer desires to amend the Plan in accordance with Section 409A in order to adopt the March 15, 2005 transition relieffor initial deferral elections; and ****

**WHEREAS**, pursuant to Section 9(d) of the Plan, the Employer has the ability toamend said Plan. 

**NOW, THEREFORE**, the Employer, in accordance with Section 9(d) of the Plan pertaining to amendments thereof,hereby amends the Plan as follows: 

1. Effective as of January 1, 2005, amend Paragraph 3 by inserting the following as the secondsentence therein: 

“Provided, however, a Key Employee may make an election to defer all or any portion of the Deferrable Compensationon or before March 15, 2005, in accordance with Q&A-21 of Notice 2005-1 and the Proposed Regulations under Section 409A of the Internal Revenue Code, so long as the Deferrable Compensation to which the deferral election relates has notbeen paid or become payable at the time of the election.” 

2. All other terms, conditions, and provisions of the Plan not hereinmodified shall remain in full force and effect. 

 

Page 1 of 2 

**IN WITNESS WHEREOF**, the Employer has caused this Amendment One to the Alabama NationalBanCorporation Plan for the Deferral of Compensation by Key Employees to be executed by its duly authorized officer as of the date first written above. 

 
**ALABAMA NATIONAL BANCORPORATION**(Employer)By: 
/s/ Richard Murray IV

Its:
 
President

Page 2 of 2
<PAGE>
                                                                    EXHIBIT 23.1

            CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We hereby consent to the incorporation by reference in the Registration
Statements on Form S-8 (No. 33-57610, No. 333-09383, No. 333-29667, No.
333-76895, No. 333-71770 and, No. 333-110151) of Trident Microsystems, Inc. of
our report dated September 3, 2004 relating to the financial statements which
appear on page 33 of this Form 10-K.




PricewaterhouseCoopers LLP
San Jose, California
September 13, 2004
Order entered December 9, 2014

In The

Court of Appeals 

Fifth District of Texas at Dallas 

No. 05-14-00695-CR

JAMES EDWARD ROGERS, JR., Appellant

V.

THE STATE OF TEXAS, Appellee

On Appeal from the 196th Judicial District Court

Hunt County, Texas

Trial Court Cause No. 28576

ORDER

The Court has before it appellant’s December 4, 2014 motion to extend time to file his 

brief December 8, 2014 motion to substitute counsel. We GRANT the motion to substitute 

counsel. We DIRECT the Clerk to substitute John Butler as appellant’s retained counsel in 

place of Sharita Blacknall.

We STRIKE the Anders brief filed by Ms. Blacknall on September 23, 2014.

We GRANT Mr. Butler’s December 4, 2014 motion to extend time to file appellant’s 

brief. We ORDER appellant to file his brief within FORTY-FIVE DAYS of the date of this 

order.

We DIRECT the Clerk to send copies of this order, by electronic transmission, to Sharita 

Blacknall, John Butler, and the Hunt County District Attorney’s Office.

/s/ ADA BROWN

JUSTICE
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          MAR-31-1998
<PERIOD-START>                             APR-01-1998
<PERIOD-END>                               JUN-30-1998
<CASH>                                           1,069
<SECURITIES>                                     1,620
<RECEIVABLES>                                    2,178
<ALLOWANCES>                                       343
<INVENTORY>                                          0
<CURRENT-ASSETS>                                 5,802
<PP&E>                                           4,206
<DEPRECIATION>                                   1,024
<TOTAL-ASSETS>                                  10,900
<CURRENT-LIABILITIES>                            2,146
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                            57
<OTHER-SE>                                       6,808
<TOTAL-LIABILITY-AND-EQUITY>                    10,900
<SALES>                                          2,106
<TOTAL-REVENUES>                                 2,106
<CGS>                                              248
<TOTAL-COSTS>                                      248
<OTHER-EXPENSES>                                  (16)
<LOSS-PROVISION>                                  (11)
<INTEREST-EXPENSE>                                  15
<INCOME-PRETAX>                                  (167)
<INCOME-TAX>                                      (43)
<INCOME-CONTINUING>                              (124)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     (124)
<EPS-PRIMARY>                                   (0.02)
<EPS-DILUTED>                                   (0.02)
        

</TABLE>
Exhibit
32.1

CERTIFICATION OF
CHIEF EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED
PURSUANT TO SECTION 906 OFTHE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly
Report of Intelligroup, Inc, (the Company) on Form 10-Q for the quarterly
period ended March 31, 2008 as filed with the Securities and Exchange Commission
on the date hereof (the Report), I, Vikram Gulati, Chief Executive Officer of
the Company, certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002 and to the best of my knowledge
and belief, that:

|(1) |  | The
      Report fully complies with the requirements of Section 13(a) or 15(d), as
      applicable, of the Securities Exchange Act of 1934, as amended (the
      Exchange Act); and
|--- |  | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|   
|(2) |  | The
      information contained in the Report fairly presents, in all material
      respects, the financial condition and results of operations of the
      Company.                  
|   

|DATE: May 06, 2008 | By: | /s/ Vikram
      Gulati
|------------------ | --- | -----------------------
|                  
|                   |     | Vikram Gulati          
|                   |     | Chief Executive Officer

31

---
Exhibit 32.4


                                  CERTIFICATION
                       PURSUANT TO 18 U.S.C. SECTION 1350,
                    AS ADOPTED PURSUANT TO SECTION 906 OF THE
                           SARBANES-OXLEY ACT OF 2002


      The undersigned hereby certify, pursuant to 18 U.S.C. Section 1350, as
adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the
undersigned's best knowledge and belief, the Annual Report on Form 10-K for the
Geodyne Energy Income Limited Partnership III-D ("Issuer") for the period ending
December 31, 2004 as filed with the Securities and Exchange Commission on the
date hereof (the "Report"):

      (a)   fully complies with the requirements of section 13(a) or 15(d) of
            the Securities Exchange Act of 1934; and

      (b)   the information contained in the Report fairly presents, in all
            material respects, the financial condition and results of operations
            of the Issuer.

      Dated this 30th day of March, 2005.

                                   GEODYNE ENERGY INCOME LIMITED
                                   PARTNERSHIP III-D
                                   ("Issuer")

                                    //s// Dennis R. Neill
                                    -----------------------------------
                                    Dennis R. Neill
                                    President (Chief Executive Officer)

                                    //s// Craig D. Loseke
                                    -----------------------------------
                                    Craig D. Loseke
                                    Chief Accounting Officer
                                    (Chief Financial Officer)
acad-ex101_184.htm



 

 

Exhibit 10.1

ACADIA Pharmaceuticals Inc. 

Description of Executive Officer Annual Incentive Cash Compensation Program 

The Compensation Committee (the “Committee”) of the Board of Directors (the “Board”) of ACADIA Pharmaceuticals Inc. (the “Company”) has recommended to the Board, and the Board has approved, an annual incentive cash compensation program for the Company’s executive officers. The program provides for an annual incentive cash compensation target equal to a percentage of each executive’s base salary.  The initial targets, which may be adjusted by the Board, are as follows: 70% for the President and Chief Executive Officer, 50% for the Executive Vice President, Head of Research and Development and the Executive Vice President, Chief Commercial Officer, and 45% for each of the Company’s other Executive Vice Presidents.  The Board will set the target percentage for any new executive officer.

Under the program, after the completion of each fiscal year, the Committee recommends to the Board for approval for each then-current executive a bonus that will be equal to an amount from 0 to 150% of the applicable target amount, which may be pro-rated for any partial year of employment. The Committee will also recommend to the Board any adjustments to the target bonus for each executive officer. In making its recommendations, the Committee assesses the level of achievement of specific criteria by the executive and the Company. These criteria include regulatory advancement or approvals for the Company’s product candidates, commercial achievements for any Company products, the advancement of the Company’s clinical programs, and other criteria the disclosure of which would reveal confidential business information and plans of the Company.